{
  "docId": "019de076-1fa8-714d-830b-c99557c4e3f8",
  "docSlug": "94eecf41575130a8334503229ea21cd4",
  "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
  "authorId": "arbutus-biopharma",
  "authorName": "Arbutus Biopharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 26,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 42,
  "notes": "The table displays mean (SE) log10 IU/mL values for various cohorts (E, F, I, J, K, G) from baseline through follow-up week 48.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-1fa8-714d-830b-c99557c4e3f8/12",
  "deckHref": "/decks/019de076-1fa8-714d-830b-c99557c4e3f8",
  "deckJsonHref": "/decks/019de076-1fa8-714d-830b-c99557c4e3f8.json",
  "deckAnchorHref": "/decks/019de076-1fa8-714d-830b-c99557c4e3f8#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.38,
        "x": 0.58,
        "y": 0.25
      },
      "kind": "list",
      "text": "All Cohorts achieved at least a -1.8 log10 decline in mean HBsAg at the end of the treatment period (Week 48). Mean HBsAg levels remained below baseline values at Follow Up Week 48. There were no significant differences in mean HBsAg declines between the 60 mg and 90 mg doses or between different dosing intervals.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb7412b6-111c-41d3-917b-13e7dcaacd19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.07,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "Data shown as mean (SE) log10 IU/mL; minimum of 5 subjects/timepoint. Last imdusiran (AB-729) dose Cohort E: Week 44, Cohorts F, I, G, K: Week 40, Cohort J: Week 36; HBsAg Assay LLOQ = 0.07 IU/mL; *N=6; #N=5",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48091410-5d4a-4a2b-bee1-a84e7aecc6e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.55,
        "x": 0.07,
        "y": 0.235
      },
      "kind": "table",
      "text": "Mean (SE) Baseline and Δ log10 HBsAg by Visit table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a020cf49-6a34-476b-8635-5b60a62bf45f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "AB-729-001: Robust HBsAg Declines Irrespective of Imdusiran Dose, Dosing Schedule, HBeAg or HBV DNA Status",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25df5a75-de72-4ca8-ab24-bc743dd15de2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 15,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "19535154-91e5-4e57-a1b7-3e1d7891f13d",
      "evidence": "emphasis on unmet medical need and treatment benefits",
      "position": 0,
      "objective": "highlight the need for HBV treatment",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}